Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Autor: Bartholomé, Emmanuel, D'Hooghe, Marie, Pandolfo, Massimo, Van Wijmeersch, Bart, Bhan, Virender, Blevins, Gregg, Brunet, Donald, Devonshire, Virginia, Duquette, Pierre, Freedman, Mark, Grand'Maison, François, Jacques, François, Lapierre, Yves, Lee, Liesly, Morrow, Sarah, Yeung, Michael, Dufek, Michal, Havrdová, Eva Kubala, Kanovsky, Petr, Stetkarova, Ivana, Talabova, Marika, Frederiksen, Jette, Kant, Matthias, Petersen, Thor, Ravnborg, Mads, Sellebjerg, Finn, Airas, Laura, Elovaara, Irina, Eralinna, Juha-Pekka, Sarasoja, Taneli, Al Khedr, Abdullatif, Brassat, David, Brochet, Bruno, Camu, William, Debouverie, Marc, Laplaud, David, Lebrun Frenay, Christine, Pelletier, Jean, Vermersch, Patrick, Vukusi, Sandra, Baum, Karl, Berthele, Achim, Faiss, Juergen, Flachenecker, Peter, Hohlfeld, Reinhard, Krumbholz, Markus, Lassek, Christoph, Maeurer, Mathias, Meuth, Sven, Ziemssen, Tjalf, Hardiman, Orla, McGuigan, Christopher, Achiron, Anat, Karussis, Dimitrios, Bergamaschi, Roberto, Morra, Vincenzo Brescia, Comi, Giancarlo, Cottone, Salvatore, Grimaldi, Luigi, Mancardi, Giovanni Luigi, Massacesi, Luca, Nocentini, Ugo, Salvetti, Marco, Scarpini, Elio, Sola, Patrizia, Tedeschi, Gioacchino, Trojano, Maria, Zaffaroni, Mauro, Frequin, Stephan, Hupperts, Raymond, Killestein, Joep, Schrijver, Hans, Van Dijl, Ronald, van Munster, Erik, Czarnecki, Maciej, Drozdowski, Wieslaw, Fryze, Waldemar, Hertmanowska, Hanka, Ilkowski, Jan, Kaminska, Anna, Klodowska-Duda, Gabriela, Maciejowski, Maciej, Motta, Ewa, Podemski, Ryszard, Potemkowski, Andrzej, Rog, Teresa, Selmaj, Krzysztof, Stelmasiak, Zbigniew, Stepien, Adam, Tutaj, Andrzej, Zaborski, Jacek, Boyko, Alexey, Chefranova, Zanna, Evdoshenko, Evgeny, Khabirov, Farit, Sivertseva, Stella, Yakupov, Eduard, Alvarez Cermeño, Jose Carlos, Escartin, Antonio, Fernandez, Oscar Fernandez, Garcia-Merino, Antonio, Hernandez Perez, Miguel Angel, Ayuso, Guillermo Izquierdo, Lallana, José Meca, Gairin, Xavier Montalban, Oreja-Guevara, Celia, Saiz Hinarejos, Albert, Gunnarsson, Martin, Lycke, Jan, Martin, Claes, Piehl, Fredrik, Roshanisefat, Homayoun, Sundstrom, Peter, Duddy, Martin, Gran, Bruno, Harrower, Timothy, Hobart, Jeremy, Kapoor, Raju, Lee, Martin, Mattison, Paul, Nicholas, Richard, Pearson, Owen, Rashid, Waqar, Rog, David, Sharrack, Basil, Silber, Eli, Turner, Ben, Williams, Anna, Woolmore, John, Young, Carolyn, Bandari, Daniel, Berger, Joseph, Camac, Ann, Cohan, Stanley, Conway, Jill, Edwards, Keith, Fabian, Michelle, Florin, Jack, Freedman, Steven, Garwacki, Dennis, Goldman, Myla, Harrison, Daniel, Herrman, Craig, Huang, Deren, Javed, Adil, Jeffery, Douglas, Kamin, Stephen, Katsamakis, George, Khatri, Bhupendra, Langer-Gould, Annette, Lynch, Sharon, Mattson, David, Miller, Tamara, Miravalle, Augusto, Moses, Harold, Muley, Suraj, Napier, James, Nielsen, Allen, Pachner, Andrew, Pardo, Gabriel, Picone, MaryAnn, Robertson, Derrick, Royal, Walter, Sheppard, Christopher, Thrower, Ben, Twyman, Cary, Waubant, Emmanuelle, Wendt, Jeanette, Yadav, Vijayshree, Zabad, Rana, Zarelli, Greg, Ho, Pei-Ran, Campbell, Nolan, Chang, Ih, Deykin, Aaron, Forrestal, Fiona, Lucas, Nisha, Yu, Bei, Arnold, Douglas L, Freedman, Mark S, Goldman, Myla D, Hartung, Hans-Peter, Miller, Aaron, Cadavid, Diego, Mikol, Dan, Steiner, Deborah

Publikováno v: In The Lancet Neurology May 2018 17(5):405-415

Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs

Autor: Monreal, Enric, Fernández-Velasco, José Ignacio, García-Sánchez, María Isabel, Sainz de la Maza, Susana, Llufriu, Sara, Álvarez-Lafuente, Roberto, Casanova, Bonaventura, Comabella, Manuel, Ramió-Torrentà, Lluís, Martínez-Rodríguez, José Enrique, Brieva, Luis, Saiz, Albert, Eichau, Sara, Cabrera-Maqueda, José María, Villarrubia, Noelia, Espiño, Mercedes, Pérez-Miralles, Francisco, Montalbán, Xavier, Tintoré, Mar, Quiroga-Varela, Ana, Domínguez-Mozo, María Inmaculada, Rodríguez-Jorge, Fernando, Chico-García, Juan Luís, Lourido, Daniel, Álvarez-Cermeño, José Carlos, Masjuan, Jaime, Costa-Frossard, Lucienne, Villar, Luisa María

Publikováno v: JAMA Neurology; April 2023, Vol. 80 Issue: 4 p397-403, 7p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

MSJ851428_supplementary_material – Supplemental material for A pharmacogenetic study implicates NINJ2 in the response to Interferon-β in multiple sclerosis

Autor: Peroni, Silvia, Sorosina, Melissa, Malhotra, Sunny, Clarelli, Ferdinando, Osiceanu, Ana Maria, Ferrè, Laura, Roostaei, Tina, Rio, Jordi, Midaglia, Luciana, Villar, Luisa María, Álvarez-Cermeño, José Carlos, Guaschino, Clara, Radaelli, Marta, Citterio, Lorena, Lechner-Scott, Jeannette, Spataro, Nino, Arcadi Navarro, Martinelli, Vittorio, Montalban, Xavier, Weiner, Howard L, Jager, Philip De, Comi, Giancarlo, Esposito, Federica, Comabella, Manuel, Martinelli-Boneschi, Filippo

Supplemental material, MSJ851428_supplementary_material for A pharmacogenetic study implicates NINJ2 in the response to Interferon-β in multiple sclerosis by Silvia Peroni, Melissa Sorosina, Sunny Malhotra, Ferdinando Clarelli, Ana Maria Osiceanu, L

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5938fa45f0c765462d11f5cf75ecc670

A pharmacogenetic study implicates NINJ2 in the response to Interferon-β in multiple sclerosis.

Autor: Peroni, Silvia, Sorosina, Melissa, Malhotra, Sunny, Clarelli, Ferdinando, Osiceanu, Ana Maria, Ferrè, Laura, Roostaei, Tina, Rio, Jordi, Midaglia, Luciana, Villar, Luisa María, Álvarez-Cermeño, José Carlos, Guaschino, Clara, Radaelli, Marta, Citterio, Lorena, Lechner-Scott, Jeannette, Spataro, Nino, Navarro, Arcadi, Martinelli, Vittorio, Montalban, Xavier, Weiner, Howard L

Publikováno v: Multiple Sclerosis Journal; Aug2020, Vol. 26 Issue 9, p1074-1082, 9p, 1 Chart, 3 Graphs